The importance of CD36 in metabolic liver disease has been suggested by the close correlation between hepatic CD36 mRNA and protein expression and the liver fat content in morbidly obese patients (119, 120), and by its elevated presence in the livers of NAFLD patients compared to healthy controls (121, 122). This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.